Exparel 266 MG/20 ML vial 20ML

Ended Awarded Last action

Contract number
SPE2DR26FHDE5
Awardee
Awarding agency
Obligated
$15,404

Award facts

Contract value 100% obligated
$15,403.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $15,403.92 delivery order to DMS Pharmaceutical Group Inc. on March 20, 2026, for EXPAREL 266 mg/20 ml vials under firm fixed-price terms.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract, a $499.999 billion acquisition vehicle supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, IL. Ultimate completion date is April 10, 2026.

Quick answers

Who was awarded contract SPE2DR26FHDE5?

SPE2DR26FHDE5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 20, 2026.

How much is contract SPE2DR26FHDE5 worth?

The government has obligated $15,404 on SPE2DR26FHDE5.

Is contract SPE2DR26FHDE5 an order under another contract?

Yes. SPE2DR26FHDE5 is a delivery order under SPE2DR25D9207, an indefinite delivery contract.

Was contract SPE2DR26FHDE5 competed?

The extent of competition for SPE2DR26FHDE5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award